DEVELOPMENT AND VALIDATION OF NEW RP-UPLC METHOD FOR THE QUANTITATIVE DETERMINATION OF OLANZAPINE IN TABLET DOSAGE FORM
Objective: to develop and validate a new very rapid, sensitive, reverse phase Ultra Performance Liquid Chromatography (RP-UPLC) technique for the estimation of Olanzapine in dosage form, as there is no official monograph & no analytical method by UPLC.
Methodology: Chromatographic separation was achieved on a Waters Acquity HSS T-3 C18 column (100 Ã— 2.1 mm, 1.8Î¼m) using an isocratic method with mobile phase composed of Potassium di-hydrogen phosphate: methanol in the ratio 60:40 v/v. The flow rate was 0.8 ml/min, temperature of the column was maintained at ambient and detection was made at 228 nm. The run time was as short as 6 min. The developed method was validated according to the International Conference on Harmonization (ICH) guidelines with respect to linearity, accuracy, precision, specificity and robustness.
Results: The developed method was linear for Olanzapine from 10 - 50 Î¼g/ml and the linear regression obtained was > 0.999. Precision, evaluated by intra- and inter-day assays had relative standard deviation (R.S.D) values within 1.5 %. Recovery data were in the range 98.2% to 100.9% with R.S.D. values < 1.5 %.
Conclusion: The method is precise, accurate, linear, robust and fast. The short retention time of 2.433 min allows the analysis of a large number of samples in a short period of time and, therefore, should be cost-effective for routine analysis in the pharmaceutical industry.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.